MENU
ITRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Iterum Therapeutics (ITRM) Ownership - Who owns Iterum Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
50.35M
P/E Ratio
N/A
Total Cash
14.5M
Projected Growth
N/A
Total Debt
22.44M
Revenue
N/A
Risk (Beta)
3.48
Dividend Yield
N/A
Total Cash/Share
0.53
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ITRM
Capitalization
50.4M
P/E Ratio
N/A
Risk (Beta)
3.48
Dividend Yield
N/A
Total Cash
14.5M
Total Cash/Share
0.53
Total Debt
22.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-11.51M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
227K
Current Ratio
0.85
Current Revenue Per Employee
770.83
Dividends Per Share - Security
N/A
EBITDA
-27.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-109.80
Shares Held By Institutions
75.9M
Shares Outstanding - Current
27.5M
Total Liabilities
27.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-7.107
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
an operator, which engages in the healthcare industry focusing on biotechnology business
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com